Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas...
-
Upload
madeleine-miller -
Category
Documents
-
view
227 -
download
0
description
Transcript of Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas...
![Page 1: Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas by Amrita Krishnan, Arturo Molina, John Zaia, David.](https://reader036.fdocuments.us/reader036/viewer/2022082403/5a4d1b6c7f8b9ab0599b3c43/html5/thumbnails/1.jpg)
Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas
by Amrita Krishnan, Arturo Molina, John Zaia, David Smith, Debbie Vasquez, Neil Kogut, Peter M. Falk, Joseph Rosenthal, Joseph Alvarnas, and Stephen J. Forman
BloodVolume 105(2):874-878
January 15, 2005
©2005 by American Society of Hematology
![Page 2: Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas by Amrita Krishnan, Arturo Molina, John Zaia, David.](https://reader036.fdocuments.us/reader036/viewer/2022082403/5a4d1b6c7f8b9ab0599b3c43/html5/thumbnails/2.jpg)
Median CD4 count trends during apheresis and after ASCT. .
Amrita Krishnan et al. Blood 2005;105:874-878
©2005 by American Society of Hematology
![Page 3: Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas by Amrita Krishnan, Arturo Molina, John Zaia, David.](https://reader036.fdocuments.us/reader036/viewer/2022082403/5a4d1b6c7f8b9ab0599b3c43/html5/thumbnails/3.jpg)
Kaplan-Meier analysis of OS in 20 patients after ASCT. .
Amrita Krishnan et al. Blood 2005;105:874-878
©2005 by American Society of Hematology
![Page 4: Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas by Amrita Krishnan, Arturo Molina, John Zaia, David.](https://reader036.fdocuments.us/reader036/viewer/2022082403/5a4d1b6c7f8b9ab0599b3c43/html5/thumbnails/4.jpg)
Kaplan-Meier analysis of OS of patients beyond 1st CR, n = 16. .
Amrita Krishnan et al. Blood 2005;105:874-878
©2005 by American Society of Hematology